Background Low lung function in early life is associated with later respiratory illness. There is limited data on lung function in African infants despite a high prevalence of respiratory disease.
Aim To assess the determinants of early lung function in African infants.
Method Infants enrolled in a South African birth cohort, the Drakenstein child health study, had lung function measured at 6–10 weeks of age. Measurements, made with the infant breathing via a facemask during natural sleep, included tidal breathing, sulfur hexafluoride multiple breath washout and the forced oscillation technique. Information on antenatal and early postnatal exposures was collected using questionnaires and urine cotinine. Household benzene exposure was measured antenatally.
Results Successful tests were obtained in 645/675 (95%) infants, median (IQR) age of 51 (46–58) days. Infant size, age and male gender were associated with larger tidal volume. Infants whose mothers smoked had lower tidal volumes (−1.6 mL (95% CI −3.0 to −0.1), p=0.04) and higher lung clearance index (0.1 turnovers (95% CI 0.01 to 0.3), p=0.03) compared with infants unexposed to tobacco smoke. Infants exposed to alcohol in utero or household benzene had lower time to peak tidal expiratory flow over total expiratory time ratios, 10% (95% CI −15.4% to −3.7%), p=0.002) and 3.0% (95% CI −5.2% to −0.7%, p=0.01) lower respectively compared with unexposed infants. HIV-exposed infants had higher tidal volumes (1.7 mL (95% CI 0.06 to 3.3) p=0.04) compared with infants whose mothers were HIV negative.
Conclusion We identified several factors including infant size, sex, maternal smoking, maternal alcohol, maternal HIV and household benzene associated with altered early lung function, many of which are factors amenable to public health interventions. Long-term study of lung function and respiratory disease in these children is a priority to develop strategies to strengthen child health.
- Paediatric Lung Disaese
- Respiratory Measurement
- Tobacco and the lung
- Clinical Epidemiology
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
What is the key question?
What are the antenatal and early-life determinants of infant lung function?
What is the bottom line?
In addition to known factors such as growth, sex and maternal smoking, maternal alcohol during pregnancy, exposure to household benzene and having an HIV-positive mother alter lung function in early life.
Why read on?
Low lung function in early life is associated with later respiratory disease. Understanding what impacts early lung function is critical in strengthening our understanding of respiratory disease risk, especially in high burden settings.
Lower respiratory tract infections (LRTIs) are the leading cause of death in children in low/middle-income countries (LMICs),1 and chronic respiratory illness is a common sequela.2 There is increasing evidence that chronic respiratory disease in later life has its origins in childhood, with low lung function in early life being associated with lung function impairment and chronic respiratory illness in later life.3 Identifying prenatal and postnatal factors associated with early lung disease, as measured by lung function, will provide a better understanding of how early-life exposures influence childhood lung disease and possibly provide insights into prevention of subsequent chronic respiratory illness. The normal development of the human lung begins in utero but continues in postnatal life until adolescence. Thus, in utero and early-life factors that damage or impair lung growth may have a considerable impact on early lung function.
Several risk factors for altered early lung function or respiratory disease in childhood have been identified including infant birth weight,4 prematurity,5 early-life respiratory tract infections,6 maternal asthma7 and environmental factors such as tobacco smoke exposure8 and household air pollution.9 Many of these factors are common in Africa but there are no data on early lung function in these settings despite the high burden of childhood respiratory disease.
We aimed to investigate the impact of antenatal and early-life exposures on lung function measured at 6 weeks of age in African infants enrolled in a birth cohort.
Infants enrolled in a birth cohort study, the Drakenstein Child Health study,10 had lung function tested. This study, set in a periurban, low socioeconomic community in South Africa, aims to investigate the epidemiology and aetiology of childhood respiratory illness and the determinants of child health. Participants were enrolled at two primary care clinics, Mbekweni, serving a predominantly black African population and Newman, serving a predominantly mixed ancestry population. Lung function testing was undertaken at the local hospital.
Infants underwent testing at 5–11 weeks of age corrected for prematurity (37 weeks). Infants born <32 weeks gestation or with congenital anomalies were excluded from this analysis. Mothers had spirometric lung function (Jaeger Masterscope, CareFusion, Switzerland) at the same visit, provided they had not had a respiratory infection within the last 2 weeks.
Information regarding antenatal, birth and early-life exposures and events were collected by questionnaire at scheduled antenatal and study visits. These are comprehensively defined in online supplementary table S1. The socioeconomic status (SES) was defined in quartiles from lowest to highest status. This score was derived from employment status and standardised scores of educational attainment, household income, assets and market access (bank accounts, shops accessed, retail accounts); this methodology has been validated for capturing SES variation within an LMIC setting.11 LRTI was defined according to WHO criteria,12 and based on confirmatory examination by trained study staff (professional nurse and/or doctor).
Maternal recurrent respiratory symptoms or low lung function was defined as at least one of doctor diagnosed asthma, chronic cough or recurrent wheeze in previous 12 months and/or low FEV1, defined as FEV1 < −1.64 SDs, predicted using the Global Lung Initiative multiethnic equations.13 Maternal distress and alcohol use during pregnancy were assessed using the self reporting questionnaire (SRQ) −20 and Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) self-reported questionnaires completed at 28–32 weeks gestation.14 The SRQ-20 is a widely used WHO-endorsed measure of psychological distress.15 We used a dichotomous score of ‘high risk’ versus ‘low risk’, with ‘high risk’ defined as a score of ≥8.15 Infants were classified as alcohol-exposed in utero if their mother reported ASSIST scored heavy exposure with high risk for alcohol related problems: daily and/or weekly use of alcohol during at least 3 months of pregnancy.
Maternal smoking history was corroborated on a quantitative analysis of maternal urine cotinine (IMMULITE 1000 Nicotine Metabolite Kit; Siemens Medical Solutions Diagnostics, Glyn Rhonwy, UK) collected antenatally and at birth. Smoking exposure based on urine cotinine was defined as follows: active smoker if urine cotinine >500 ng/mL, passive smoker if urine cotinine 10–500 ng/mL and non-smoker if urine cotinine <10 ng/mL.16 Maternal urine was collected for cotinine testing at the second antenatal study visit (28–32 weeks gestation) and at birth, with the higher result used to classify smoking levels. Benzene, a household air pollutant, was measured at an antenatal home visit using a Markes thermal desorption tube left in the home for 2 weeks.17 The South African National Ambient Air Quality standard of 5 μg/m3 was used to define above and below threshold values for benzene.17
Infant lung function measurements
Lung function measurements included tidal breathing and flow volume loops (TBFVL), sulfur hexafluoride (SF6) multiple breath washout (MBW) and the forced oscillation technique (FOT). Infants were tested from July 2012 to December 2014 for TBFVL and MBW and, for operational reasons, from October 2012 to December 2014 for FOT. Lung function was measured in unsedated infants during quiet sleep and conformed to American Thoracic society/European Thoracic society (ATS/ERS) guidelines,18 ,19 as previously published.20 ,21
Tidal breathing measures of tidal volume (VT), respiratory rate and expiratory flow ratios were collected using the Exhalyser D with ultrasonic flow metre (Ecomedics, Duernton, Switzerland) and analysed using analysis software (WBreath V.3.28.0; Ndd Medizintechnik, Zurich, Switzerland), as described previously.20 MBWs measuring the functional residual capacity (FRC) and lung clearance index (LCI) were performed using 4% SF6 as a tracer gas and ultrasonic flow metre (Spirison, Ecomedics) with acquisition and analysis software (WBreath V3.28.0, Ndd Medizintechnik) as reported previously.22 Measurements of respiratory system resistance (RRS) and compliance (CRS) with the FOT were made with purpose built equipment (University of Szeged, Hungary) using a medium frequency signal, as previously reported.21 ,23
The study was approved by the Faculty of Health Sciences, Human Research Ethics Committee, University of Cape Town (401/2009) and by the Western Cape Provincial Health Research Committee. Mothers gave written informed consent in their first language for participation.
Lung function outcomes were modelled using multiple linear regression to assess the impact of different antenatal and early-life exposures on lung function at 6–10 weeks. A base model was constructed using Directed Acyclic Graph (DAG) for confounder selection using graphical interface software DAGitty (http://www.dagitty.net V.2.2, 2014), (see online supplementary figure S2).24 DAG minimal adjusted set of variables were selected using a step-by-step approach.25
Interactions were then explored between infant growth and lung maturation (weight for age z score, gestation, birth weight z score), sex, ethnicity, environmental and socioeconomic factors (tobacco smoke exposure, high household benzene, SES), maternal factors (maternal stress score, infant feeding, maternal respiratory health, maternal HIV, antenatal alcohol) and previous LRTI, for each lung function outcome separately. Confounders and interactions were included in the final model for each outcome if they were associated with p value of <0.5 and/or the association had biological plausibility based on previous literature, as shown in online supplementary tables S2–S10.
Statistical analyses were performed using STATA V.13 for windows (STATA, College Station, Texas, USA). Data are presented as mean and SD for normally distributed variables and median and IQR for non-normally distributed variables. Weight (WAZ) and height (HAZ) for age z scores were calculated using the WHO Child Growth Standards ‘I grow up’ STATA package.26
Between July 2012 and December 2014, 690 infants were tested, of whom 15 were excluded as they were very preterm (13 (2%)) or had congenital abnormalities (2 (0.3%)) (figure 1). Infant testing was done at a median (IQR) of 51 (46–58) days, and anthropometry of enrolled infants is shown in table 1.
Infants from Mbekweni, who were predominantly black African infants, were of lower SES, less likely to have been breastfed and had higher HIV exposure compared with mixed ancestry infants, who had higher rates of tobacco smoke exposure (table 2).
Despite an HIV prevalance of 19%, no infants were HIV infected due to a strong prevention of mother-to-child transmission programme that included antiretroviral therapy to all HIV-infected pregnant women and to infants for 6 weeks postpartum.
Successful measurements were obtained in 649 (95%) of tidal breathing, 614 (90%) MBW and 508/645 (79%) FOT measures (see online supplementary table S2).
Associations of early lung function
The results of the univariate and multivariate analyses of associations with lung function measures are shown in online supplementary tables S3–S11, and the results of the multivariate analyses are summarised below.
Infant growth and lung maturation
Infant size, age and WAZ were associated with larger VT, with VT increasing by 2.5 mL for every unit increase in WAZ (p<0.001; 95% CI 1.9 to 3.1). Birth weight z score was associated with lower respiratory rate (difference −3 bpm (95% CI −4 to −1), p<0.001), larger FRC (4 mL (1.8 to 6.1), p<0.001) and higher CRS (0.06 mL/cmH2O (0.01 to 0.12), p=0.03). Gestational age was associated with a small but statistically significant decrease in respiratory rate (−1 bpm per week increase; (−1.4 to −0.1), p=0.02), increased VT (0.4 mL (0.1 to 0.7), p=0.006), larger FRC (2.6 mL 90.3 to 2.2) p=0.01) and increased CRS (0.03 mL/cmH2O (0.006 to 0.06), p=0.02) at 6–10 weeks of age. However, neither somatic growth at birth nor at testing nor gestational age was associated with the tidal expiratory flow ratio of time to peak tidal expiratory flow over total expiratory time (tPTEF/tE) and RRS.
Sex and ethnicity
Male infants had larger VT compared with female infants (2.4 mL difference (95% CI 1.4 to 3.4), p<0.001) but lower tPTEF/tE (−3.2% (−5.5 to −1.0), p=0.005), higher RRS (4.1 cmH2O s/L (1.0 to 7.3), p=0.01) and lower CRS (−0.12 mL/cmH2O (−0.2 to −0.03), p=0.008).
Black African infants had a higher respiratory rate (3.6 bpm difference (95% CI 1.05 to 6.1), p=0.006), increased tPTEF/tE (4.4% (1.7 to 7.2), p=0.002) and increased inspiratory time over total breath time (tI/tTOT) (1.3% (0.2 to 2.4), p=0.02), but similar VT compared with infants of mixed ethnicity. Ethnicity had no effect on other lung function outcomes measured (see online supplementary tables S2–S10).
Socioeconomic and environmental factors
Infants whose mothers smoked during pregnancy had lower VT (−1.6 mL (95% CI −3.0 to −0.1), p=0.04) and higher LCI (0.1 FRC turnovers (0.01 to 0.3), p=0.03) compared with infants whose mothers did not smoke during pregnancy. The tPTEF/tE, FRC and CRS were also lower in smoke-exposed compared with non-exposed infants, but these did not remain statistically significant after correcting for predictors and confounders. Infants living in homes with high levels of household benzene had lower tPTEF/tE (−3.0% (−5.2 to −0.7), p=0.01) compared with infants from low-level households (see online supplementary figure S2). Household benzene exposure had no effect on other lung function outcomes. SES was not associated with lung function differences.
High maternal distress scores, breastfeeding practises and history of maternal recurrent respiratory symptoms were not associated with lung function outcomes. Infants of HIV-infected mothers had higher VT (1.7 mL (95% CI 0.06 to 3.3), p=0.04) compared with infants who were not HIV exposed, but no other differences in lung function were observed.
Infants whose mothers drank alcohol during pregnancy had lower respiratory rates (−7 bpm (−13 to −2), p=0.009), higher tidal volumes (3.0 mL (CI 0.4 to 5.5), p=0.02) and lower tPTEF/tE (−10% (−15.4 to −3.7), p=0.002) compared with infants whose mothers did not drink alcohol (see online supplementary figure S3).
This is the first study from a low-middle income country setting to show several antenatal and early-life factors that impact on lung function, affecting both lung structure and control of breathing in 6-week-old African infants. Known factors such as infant growth, sex and maternal smoking and novel risk factors such as maternal alcohol ingestion and HIV exposure were identified.
We have published methodology using the FOT in this cohort, showing it to be sensitive enough to detect the impact of sex and antenatal smoke exposure on lung function23 and have defined normative data in these infants.28 This paper analyses the impact of antenatal factors on early lung growth and function in a large cohort of infants. Different antenatal and early-life exposures affected either lung structural development as evidenced by reduced lung volumes and lung compliance or control of breathing with effects on respiratory rate and flow ratios or both. Somatic growth, age and gestational age primarily affected lung development, while ethnicity, alcohol exposure, HIV exposure or benzene affected control of breathing, sex and tobacco smoke exposure affected both.
Infant size, in particularly length, is an important predictor of lung function outcomes early in life.29–31 As both weight and length at test were strongly associated with lung function outcomes in our study, we included only one measure of infant size, weight at test, in our model. As expected infant size at birth and a few weeks postnatally was associated with increased lung size and CRS at 6 weeks. Size at birth is associated with early lung development.32 The fact that resistance was not associated with somatic growth in this study is likely related to the measurement method which, by using a mask over the mouth and nose, includes the resistance of the upper airway which is large and dominates the measured effect on the RRS.33
Our findings of sex differences in lung function are consistent with previous reports of low lung function in male infants,34 ,35 which suggest that male infants have relatively smaller airways for lung size compared with female infants. Lower early lung function in boys may be one factor contributing to the higher rate of LRTI in boys.36
The effect of ethnic differences may be difficult to distinguish from sociocultural and environmental factors. However, even after adjusting for exposure differences, lung function remained different between black African and mixed ancestry infants. Black African infants had higher respiratory rate and higher flow ratios, but similar lung volumes and impedance to mixed ancestry infants, suggesting a different early pattern of breathing in African infants. This is consistent with previously described ethnic differences between black Afro-Caribbean and Caucasian European infants.34 ,37 ,38
Smoke-exposed infants had smaller lung volumes suggesting early structural lung impairment. Previous studies have shown that both in utero smoke exposure37 and early-life environmental exposure to tobacco smoke (ETS) impair early lung function.8 In this study, we were unable to distinguish between the effect on lung function of in utero or early-life smoke exposure as lung function was measured a few weeks after birth. As our cohort had an extremely high passive smoke exposure rate (75%), it is likely that some of the effects seen are due to ETS in early life. Although altered control of breathing has been described in smoke-exposed infants,39 our lung function measures may not be sensitive nor specific enough to detect these effects.
Infants exposed to high household benzene levels had lower tPTEF/tE which may be related to airway obstruction or to breathing pattern. The tI/tTOT more specifically reflects the central control of breathing, but was not associated with benzene exposure in this study. Further research evaluating the impact of antenatal and early exposure to indoor air pollutants on lung health is needed.
SES did not impact lung function outcomes. This may reflect the overall poor SES of the populations studied. Prior LRTI also did not affect lung function; however, the number of children with LRTI was very small, and the study was therefore not adequately powered to investigate this.
Consistent with several other studies, we found no association between maternal chronic respiratory illness and infant lung function.40–42
This is the first study to show an effect of alcohol exposure on infant lung function. The deleterious effect of alcohol exposure on the developing fetal brain is well understood and described, providing a possible basis for altered control of breathing in alcohol-exposed infants. In addition, in utero alcohol exposure reduces surfactant protein and alveolar macrophage function and increases lung susceptibility to trauma and infection in animal models.43 ,44 Animal studies have also shown alcohol exposure during pregnancy to impact lung growth and structure,45 although some do not persist into early postnatal life.46 The number of alcohol-exposed infants included was small, and hence this result should be interpreted with caution and confirmed in a larger cohort. Further, in this study alcohol exposure may have been underestimated due to underreporting. However, this represents the minimum number of alcohol-exposed infants, with a very strong association for impaired lung function demonstrated. Further research of the potential mechanisms and impact is needed.
This is also the first study to show an association between HIV exposure and lung function, with exposed infants having higher VT, suggesting an effect on control of breathing. This effect may be mediated through HIV or due to antiretroviral therapy taken by mothers and infants with dysregulation of metabolic pathways. Further research is needed including long-term follow-up of infants, which we are currently undertaking.
Strengths of this study include the large sample size, the high success rate of testing, the comprehensive lung function testing that was done and the measurement of many, diverse potential risk factors that may impact on lung function. In addition, this is the first study to provide lung function measurements in African infants. A limitation is the possible lack of generalisability to other LMICs or to other ethnic groups. However, many of the risk factors described are highly prevalent in LMICs. In addition, our model had low R2 values (see online supplementary tables S1–S9), suggesting that there are other unaccounted for factors contributing to early-life lung function.
We identified several risk factors for impaired lung function that are amenable to public health interventions and several that require further study, including maternal HIV infection and use of alcohol during pregnancy. Avoidance of maternal smoking and smoking cessation programme for pregnant women should be a priority, and implementing strategies to reduce exposure to benzene should be undertaken in this population. Long-term study of lung function and respiratory health in these infants is a priority that we are undertaking to better understand the clinical implications of these findings and to inform new strategies to strengthen child health in LMICs.
The authors thank the study and clinical staff at Paarl Hospital, Mbekweni and TC Newman clinics and the CEO of Paarl Hospital, Dr Kruger and the Western Cape Health Department for their support of the study. The authors acknowledge the assistance of Tim Rosenow and Georgia Banton from the Telethon Kids Institute for their assistance with technical advice and data analysis. The authors thank the families and children who participated in this study.
GLH and HJZ contributed equally as senior authors.
Contributors DG, GLH and HJZ conceived the study; DG, PDS, ZH, AV, DJS, GLH and HJZ contributed to the study design; LW, AA, AV and NK recruited patients and collected data; DG, LW and AA recorded measurement data; DG, DC and PN processed the recordings and analysed the data; DG, GLH and HJZ drafted the manuscript; all authors have seen and approved the submitted manuscript.
Funding This study was supported by grants from the Wellcome Trust (No. 098479/z/12/z), Bill and Melinda Gates Foundation (OPP1017641), Worldwide University Network Research Mobility Award, University of Cape Town equipment grant, the Hungarian Scientific Research Fund (No. 105403) and Thrasher Foundation (No. 9207). GLH is funded by the National Health and Medical Research Foundation of Australia (No. 1025550). PDS is funded by the National Health and Medical Research Foundation of Australia (No. 1002035). ZH was supported by a travel grant from MGC Diagnostics. HJZ and DJS are supported by the South African Medical Research Council.
Competing interests None.
Ethics approval Faculty of Health Sciences Research Ethics Committee, University of Cape Town.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data generated during the project are kept in the Drakenstein Child Health Study Data repository which is password protected and anonymised. Data are freely available to the study investigators. Data deposited into Drakenstein Child Health Study Data Repository will be maintained for a minimum of 20 years. There are no security, licensing or ethical issues related to the included data, and all data used in the project have been generated directly as a result of the project, without any pre-existing data being used.